In humanized mouse models, Tessera is demonstrating LNP delivery of gene writers to, and rewriting of, hematopoietic stem cells to an extent that could be curative in sickle cell disease

Ring Therapeutics believes that the next great viral vector is a ubiquitous, but little known, family of viruses already found in the body